Tag: COVID-19

  • Continuing Trending of Monkeypox and Covid

    Continuing Trending of Monkeypox and Covid

    Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to lower risk of COVID, poor outcomes. At least 150 minutes (2.5 hours) of moderate physical activity—or 75 minutes (1.2 hours) of vigorous exercise—weekly was linked to a lower risk of […]

  • Southern Hemisphere Flu Season Bodes Ill for U.S.

    Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19 boosters in young kids. Data collected from two vaccine safety surveillance programs in the first 10 weeks of administration of third doses of the Pfizer/BioNTech COVID-19 to US children aged […]

  • Monkeypox Takes Headlines as COVID Turns a Corner

    Key Points: In today’s Recommendation for Industry, we discuss the ongoing monkeypox headlines. Read more below. US COVID cases show hints of decline. The 7-day average for new daily cases has dipped slightly to the 120,000 range over the past 3 days, according to an analysis by the Washington Post. Meanwhile, the 7-day average for new […]

  • Indicators Point to CDC Reductions in COVID Control Guidelines

    Key Points: In today’s Recommendation for Industry, we discuss CDC’s reduction in COVID guidelines. Read more below. New York Times reports updates about COVID: Hospitalizations continue to increase, as they have through the summer, but they remain well below the peaks reached in previous surges. Nationwide, around 43,000 people are hospitalized with the coronavirus on […]

  • Is There a Risk of Monkeypox Workplace Transmission?

    Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces US contract for 66 million bivalent booster doses. Moderna announced a deal worth $1.76 billion with the US government to supply an initial 66 million doses for a new COVID-19 […]

  • COVID Vaccines Continue to Evolve

    Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines. Federal officials have signaled that second boosters for those under 50 are on hold to speed production of new bivalent shots. The new bivalent booster shots will include the original […]

  • COVID Cases Rise Again – but Don’t Overreact

    Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains more ground. On July 19, CDC vaccine advisers unanimously approved recommended the use of the Novavax COVID-19 vaccine for the primary series for people 18 years and older. The CDC […]

  • BA.5 Continues Transmission, but Severity is Low

    Key Points: In today’s Recommendation for Industry, we discuss BA.5’s continued transmission and low severity. Read more below. FDA green-lights Novavax vaccine as COVID-19 levels rise: While the FDA has approved emergency use authorization for Novavax vaccine, the CDC must recommend it before it can be administered. The CDC Advisory Committee on Immunization Practices (ACIP) […]

  • Westward Wave of COVID Continues – as Projected

    Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvante. On July 13, the USDA issued an emergency use authorization for Novavax COVID-19, Adjuvante vaccine for individuals 18 years of age and older. The FDA […]

  • Question on COVID Transmission from Packaging Resurfaces

    Key Points: In today’s Recommendation for Industry, we discuss the possibility of COVID transmission from packaging. Read more below. Nitric oxide boosts oxygen in pregnant women with COVID-19 pneumonia. Inhaled high-dose nitric oxide (INO200) safely shortened time on supplemental oxygen and hospital stays among pregnant women diagnosed as having severe bilateral COVID-19 pneumonia, suggests a […]